10/31/2026
A study published in the American Journal of Veterinary Research compared the pharmacokinetics of intact, split, and crushed extended-release levetiracetam (LEV-XR) tablets in seven healthy Beagles following administration of a 500 mg dose.
The findings revealed important differences between splitting and crushing:
- 𝗦𝗽𝗹𝗶𝘁𝘁𝗶𝗻𝗴: No statistically significant differences were found in the evaluated pharmacokinetic parameters between split and intact tablets. Splitting may provide a practical option for dose adjustment in smaller dogs.
- 𝗖𝗿𝘂𝘀𝗵𝗶𝗻𝗴: Crushed tablets produced a higher maximum plasma concentration (61.5 vs 46.0 µg/mL) but lower drug exposure during the final four hours of the 12-hour dosing interval (AUC₈₋₁₂ₕ: 30.0 vs 49.8 µg·h/mL).
- 𝗗𝘂𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝗯𝗼𝘃𝗲 𝘁𝗮𝗿𝗴𝗲𝘁 𝗰𝗼𝗻𝗰𝗲𝗻𝘁𝗿𝗮𝘁𝗶𝗼𝗻: Plasma concentrations remained above the study's target of 10 µg/mL for approximately 8.5 hours with crushed tablets, compared with 10.9 hours with intact tablets.
An exploratory pharmacokinetic model also estimated an earlier time to maximum concentration with crushed tablets, although the observed difference in time to peak was not statistically significant.
These findings suggest that splitting and crushing extended-release levetiracetam are not pharmacokinetically equivalent. Splitting may facilitate dose adjustment, whereas crushing alters the drug's concentration-time profile.
The authors proposed further investigation of crushed LEV-XR for managing cluster seizures when immediate-release levetiracetam is unavailable. However, clinical efficacy during seizures was not evaluated, and this potential application remains unproven.
𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝗹𝗶𝗺𝗶𝘁𝗮𝘁𝗶𝗼𝗻𝘀: The study included only seven healthy Beagles and evaluated one extended-release product. The dogs were fasted, and crushed tablets were suspended in water before administration. The 10 µg/mL target was based on human therapeutic reference values, as a validated therapeutic concentration range has not been established in dogs. Therefore, the findings should not automatically be generalized to other formulations or interpreted as evidence of clinical efficacy.
Follow 𝗩𝗲𝘁𝗘𝗱 on Facebook and Instagram for more veterinary updates.
Mondino A, Nettifee JA, Simon KE, Papich MG, Muñana KR. Tablet crushing, but not splitting, alters the pharmacokinetics of extended-release levetiracetam in dogs. American Journal of Veterinary Research. Published online October 23, 2026. doi:10.2460/ajvr.26.08.0360